LifeStance Health Group (NASDAQ:LFST) Director Robert Bessler Sells 894,337 Shares

LifeStance Health Group, Inc. (NASDAQ:LFST) Director Robert Bessler sold 894,337 shares of the firm’s stock in a transaction on Friday, June 26th. The shares were sold at an average price of $10.13, for a total transaction of $9,059,633.81. Following the completion of the transaction, the director directly owned 539,763 shares of the company’s stock, valued at approximately $5,467,799.19. The trade was a 62.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Robert Bessler also recently made the following trade(s):

• On Tuesday, May 12th, Robert Bessler sold 575,034 shares of LifeStance Health Group stock. The stock was sold at an average price of $8.02, for a total transaction of $4,611,772.68.
• On Thursday, May 7th, Robert Bessler sold 75,000 shares of LifeStance Health Group stock. The stock was sold at an average price of $8.55, for a total value of $641,250.00.
• On Friday, April 24th, Robert Bessler sold 62,147 shares of LifeStance Health Group stock. The shares were sold at an average price of $7.05, for a total value of $438,136.35.
• On Thursday, April 23rd, Robert Bessler sold 7,752 shares of LifeStance Health Group stock. The stock was sold at an average price of $7.00, for a total value of $54,264.00.
• On Tuesday, April 21st, Robert Bessler sold 5,101 shares of LifeStance Health Group stock. The stock was sold at an average price of $7.01, for a total value of $35,758.01.

LifeStance Health Group Price Performance

NASDAQ LFST traded up $0.40 during trading on Tuesday, reaching $10.74. The company’s stock had a trading volume of 3,824,610 shares, compared to its average volume of 3,328,169. The firm has a fifty day moving average of $7.98 and a 200 day moving average of $7.28. LifeStance Health Group, Inc. has a one year low of $3.74 and a one year high of $10.89. The stock has a market capitalization of $4.17 billion, a PE ratio of 179.07 and a beta of 1.19. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.48 and a quick ratio of 1.48.

LifeStance Health Group (NASDAQ:LFST) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.04 EPS for the quarter, topping the consensus estimate of $0.01 by $0.03. LifeStance Health Group had a return on equity of 1.56% and a net margin of 1.55%.The company had revenue of $403.48 million during the quarter, compared to analyst estimates of $387.46 million. The business’s revenue was up 21.2% compared to the same quarter last year. Analysts expect that LifeStance Health Group, Inc. will post 0.12 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on LFST shares. Barclays boosted their price target on shares of LifeStance Health Group from $8.00 to $9.00 and gave the stock an “overweight” rating in a research note on Friday, March 6th. JPMorgan Chase & Co. raised their price objective on shares of LifeStance Health Group from $8.00 to $9.00 and gave the company a “neutral” rating in a research report on Thursday, May 14th. The Goldman Sachs Group started coverage on shares of LifeStance Health Group in a report on Friday, June 5th. They set a “neutral” rating and a $9.00 price objective for the company. BTIG Research increased their target price on LifeStance Health Group from $11.00 to $12.00 and gave the company a “buy” rating in a research note on Friday, May 8th. Finally, Wall Street Zen cut LifeStance Health Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 13th. Two investment analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, LifeStance Health Group presently has a consensus rating of “Moderate Buy” and an average price target of $9.75.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the business. Bank of America Corp DE boosted its stake in shares of LifeStance Health Group by 165.0% in the 1st quarter. Bank of America Corp DE now owns 1,994,027 shares of the company’s stock valued at $12,702,000 after purchasing an additional 1,241,475 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in LifeStance Health Group by 359.1% in the first quarter. EverSource Wealth Advisors LLC now owns 6,909 shares of the company’s stock worth $44,000 after purchasing an additional 5,404 shares during the last quarter. California State Teachers Retirement System boosted its position in LifeStance Health Group by 32.1% during the first quarter. California State Teachers Retirement System now owns 166,084 shares of the company’s stock valued at $1,058,000 after buying an additional 40,402 shares during the period. Quantinno Capital Management LP grew its stake in shares of LifeStance Health Group by 46.4% during the first quarter. Quantinno Capital Management LP now owns 22,210 shares of the company’s stock valued at $141,000 after buying an additional 7,043 shares during the last quarter. Finally, Orbimed Advisors LLC bought a new position in shares of LifeStance Health Group during the first quarter valued at about $3,185,000. 85.50% of the stock is owned by hedge funds and other institutional investors.

LifeStance Health Group Company Profile

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.